Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
A structure-function approach to optimizing TLR4 ligands for human vaccines.
Carter D, Fox CB, Day TA, Guderian JA, Liang H, Rolf T, Vergara J, Sagawa ZK, Ireton G, Orr MT, Desbien A, Duthie MS, Coler RN, Reed SG. Carter D, et al. Clin Transl Immunology. 2016 Nov 2;5(11):e108. doi: 10.1038/cti.2016.63. eCollection 2016 Nov. Clin Transl Immunology. 2016. PMID: 27990284 Free PMC article.
Adjuvants are combined with vaccine antigens to enhance and modify immune responses, and have historically been primarily crude, undefined entities. Introducing toll-like receptor (TLR) ligands has led to a new generation of adjuvants, with TLR4 ligands being …
Adjuvants are combined with vaccine antigens to enhance and modify immune responses, and have historically been primarily crude, undefined e …
In silicon desinging of RANKL-targeting vaccine for protection of osteoporosis based on the epitope of Denosumab.
Wu T, Guan B, Luo J, Li L, Zhang B, Yang Z, Tan L, Tao H. Wu T, et al. Int Immunopharmacol. 2025 Jan 10;144:113610. doi: 10.1016/j.intimp.2024.113610. Epub 2024 Nov 23. Int Immunopharmacol. 2025. PMID: 39580862 Free article.
To address these challenges, vaccine-based approach has been adopted to achieve sustainable protection through induction and maintenance of effective antibodies in mild level over decades. ...This molecule was comprised of 46.5 % of helix, 8.5 % strand and 45.1 % coil, the …
To address these challenges, vaccine-based approach has been adopted to achieve sustainable protection through induction and maintena …